Not Tagged
Not Tagged
['hodgkin', 'lymphoma']
 presenting the 1st phase 3 trial adding #brentuximab in high risk hodgkin #lymphoma in pediatric population. better 3yr efs in the arm receiving brentuximab. #asco22 #asco2022 
Assist-Prof of Med, @MayoClinic FL, #ASCOTEC, ASCO AMEC. #Lymphoma #PTCL #CTCL #histiocyticDiseases #ClinicalResearch ?????? ????? ?? ?????? #???????